Smad1/5 Antikörper (AA 361-465)
-
- Target Alle Smad1/5 (SMAD1/5) Produkte
- Smad1/5 (SMAD1/5) (Smad1/5 Protein (SMAD1/5))
-
Bindungsspezifität
- AA 361-465
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Smad1/5 Antikörper ist unkonjugiert
-
Applikation
- Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Flow Cytometry (FACS), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), ELISA, Immunocytochemistry (ICC)
- Kreuzreaktivität
- Human
- Homologie
- Mouse,Rat,Dog,Cow,Pig,Horse,Rabbit
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human Smad 5
- Isotyp
- IgG
-
-
- Applikationshinweise
-
ELISA 1:500-1000
FCM 1:20-100
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- by
- Alamo Laboratories Inc
- No.
- #029752
- Datum
- 03.07.2014
- Antigen
- Chargennummer
- 120918
- Validierte Anwendung
- Western Blotting
- Positivkontrolle
- Hela cells
- Negativkontrolle
- c6/36 cells (non-reactive species)
- Bewertung
- A single major band was observed in the positive control at the correct molecular weight. Several additional faint bands appeared in both the positive and negative controls, but they did not indicate significant non-specific interaction.
- Primärantikörper
- Antigen: SMAD, Mothers Against DPP Homolog 1 (SMAD1) (1:200 dilution)
- Catalog number: ABIN732158
- Lot number: 120918
- Sekundärantikörper
- Antibody: Goat Anti-Rabbit IgG (H + L)-HRP Conjugate (1:20,000 dilution)
- Lot number: L170-6515
- Full Protocol
- 1. Total protein extracts were boiled in 1X SDS Sample Buffer containing 1% SDS and 1.25% β-mercaptoethanol at 95°C for 5 min prior to loading.
- 2. 58 μg of boiled extracts were loaded and resolved on 8-16% SDS-polyacrylamide gel.
- 3. The Thermo Scientific - Spectra Multicolor Broad Range (Cat # 26634) were used as molecular mass markers.
- 4. Proteins were then transferred onto PVDF membrane by wet transfer and protein transfer was confirmed with Ponceau-S staining.
- 5. The PVDF membrane was incubated with 25 mL of blocking buffer [Tris Buffered Saline, pH 7.4 plus 0.1% TW20 (TBST)] containing 5% (W/V) BSA at room temperature for 1 h.
- 6. The membrane was rinsed with TBST once.
- 7. The membrane was immersed with the protein side up in the primary antibody solution (anti-SMAD1; 1:200) in TBST containing 5% (W/V) BSA and incubated for 16 h at 4°C.
- 8. The membrane was rinsed in TBST thrice for 5 min each.
- 9. The membrane was incubated in the HRP-conjugated secondary antibody solution (Goat anti-rabbit IgG-HRP; 1:20,000) in TBST containing 5% (W/V) BSA and incubated for 1 h at room temperature (~26°C) with gentle agitation.
- 10. The membrane was rinsed in TBST thrice for 5 min each.
- 11. The membrane was rinsed in TBS twice for 30 s each.
- 12. Signals were detected with ECL-2 Substrate. The blot was scanned for 300 s.
- 13. The membrane was rinsed three times TBST.
- 14. Incubated in Acidic Glycine Stripping Buffer at room temperature with gentle agitation for 3 times, 10 min each.
- 15. The membrane was washed in TBST 2 times for 10 min each.
- 16. Repeated Steps 5-12 with the loading control antibody (anti-Actin; 1:6,000) and its matching secondary antibody (Goat anti-rabbit IgG-HRP; 1:20,000).
- Anmerkungen
- - No experimental challenges noted.
Validierung #029752 (Western Blotting)ValidierungsbilderProtokoll -
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Haltbarkeit
- 12 months
-
-
MiR-199a-3p suppresses proliferation and invasion of prostate cancer cells by targeting Smad1." in: Oncotarget, Vol. 8, Issue 32, pp. 52465-52473, (2017) (PubMed).
: "Smurf1 inhibits integrin activation by controlling Kindlin-2 ubiquitination and degradation." in: The Journal of cell biology, Vol. 216, Issue 5, pp. 1455-1471, (2017) (PubMed).
: "
-
MiR-199a-3p suppresses proliferation and invasion of prostate cancer cells by targeting Smad1." in: Oncotarget, Vol. 8, Issue 32, pp. 52465-52473, (2017) (PubMed).
-
- Target
- Smad1/5 (SMAD1/5) (Smad1/5 Protein (SMAD1/5))
- Andere Bezeichnung
- Smad1 + Smad5 (SMAD1/5 Produkte)
- Hintergrund
-
Synonyms: Mothers against decapentaplegic homolog 5, SMAD5, Mothers against decapentaplegic homolog 1, SMAD1
Background: Transcriptional modulator activated by BMP (bone morphogenetic proteins) type 1 receptor kinase. SMAD5 is a receptor-regulated SMAD (R-SMAD). Transcriptional modulator activated by BMP (bone morphogenetic proteins) type 1 receptor kinase. SMAD1 is a receptor-regulated SMAD (R-SMAD). SMAD1/OAZ1/PSMB4 complex mediates the degradation of the CREBBP/EP300 repressor SNIP1. May act synergistically with SMAD4 and YY1 in bone morphogenetic protein (BMP)-mediated cardiac-specific gene expression.
- Gen-ID
- 4090, 4086
-